Polaris Venture Management Co. V as of Dec. 31, 2020
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 8 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics Common Stock (FATE) | 67.6 | $52M | 570k | 90.93 | |
| Lyra Therapeutics Common Stock (LYRA) | 16.4 | $13M | 1.1M | 11.40 | |
| Selecta Biosciences Common Stock | 11.0 | $8.4M | 2.8M | 3.03 | |
| x4 Pharmaceuticals Common Stock (XFOR) | 2.6 | $2.0M | 312k | 6.43 | |
| Atyr Pharma Common Stock | 0.7 | $507k | 131k | 3.88 | |
| Genocea Biosciences Common Stock (GNCAQ) | 0.6 | $478k | 197k | 2.42 | |
| Dare Bioscience Common Stock | 0.6 | $437k | 326k | 1.34 | |
| Pulmatrix Common Stock | 0.6 | $428k | 359k | 1.19 |
